Characterization of AQX-1125, a small-molecule SHIP1 activator

Characterization of AQX-1125, a small-molecule SHIP1 activator

(2012) Grant R Stenton et al.   BRITISH JOURNAL OF PHARMACOLOGY

MyD88-Dependent SHIP1 Regulates Proinflammatory Signaling Pathways in Dendritic Cells after Monophosphoryl Lipid A Stimulation of TLR4

(2011) Caglar Cekic et al.   JOURNAL OF IMMUNOLOGY

Genetic Segregation of Inflammatory Lung Disease and Autoimmune Disease Severity in SHIP-1-/- Mice

(2011) M. J. Maxwell et al.   JOURNAL OF IMMUNOLOGY

Targeting Phosphoinositide-3-Kinase-δ with Theophylline Reverses Corticosteroid Insensitivity in Chronic Obstructive Pulmonary Disease

(2010) Yasuo To et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

SHIP deficiency causes Crohn's disease-like ileitis

(2010) W. G. Kerr et al.   GUT

Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease

(2010) John Marwick   International Journal of Chronic Obstructive Pulmonary Disease

Inhibition of PI3Kδ Restores Glucocorticoid Function in Smoking-induced Airway Inflammation in Mice

(2009) John A. Marwick et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

SHIP1 Is a Repressor of Mast Cell Hyperplasia, Cytokine Production, and Allergic Inflammation In Vivo

(2009) D. J. Haddon et al.   JOURNAL OF IMMUNOLOGY